Icon

Sancuso - ( 3.1 mg/24 hr; Film, Extended Release, Transdermal)

Granisetron Hydrochloride Kyowa
3.1 mg/24 hr; Film, Extended Release, Transdermal
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
None
None None
Indicated for the prevention of nausea and vomiting in patients receiving moderately and/or highly emetogenic chemotherapy regimens of up to 5 consecutive days duration.
Yes
**** ** *** ***** ** **** **** ** **** ****** '*** (*** **, ****) *** *** ************ *********. ***** ***** **** ****** '*** (*** **, ****) ** ***** *** ********* ** ****, ***** **** ****** ****** *** ******* **** *** **, ****. ******* ******* ******** ******** *****'* ******** **** '*** (*** **, ****) ****** ** ******** ** ****.
Sancuso Patent 1
**** **** ** **
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
**** *** \ ** **** **, **** **** ** ** **** ***** *** ****
  1. *** *, **** : **** (*******) ******** ***** (**********) ***** *** **** ** **** ****** '*** (*** **, ****).
  2. *** **, **** : ***** (**********) ***** * **** ******* **** ** ******** ***** ** ******* ******** ** ***** ******** ********.
  3. *** **, **** : ***** ***** **** **** ********* ****** '*** (*** **, ****) *** **** *** ****** ** *****.
  4. *** **, **** : ******* ******* ******** ******** *****'* ******** **** '*** (*** **, ****) ****** ** ******** ** ****.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.